Recent Finacing
Recent Raise
Cell Medica develops and manufactures autologous and engineered T‑cell immunotherapies—EBV‑targeting baltaleucel‑T and Cytovir antiviral products—using CAR and TCR platforms and collaborations to enable allogeneic and antibody‑secretion engineering.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors